This topic contains a solution. Click here to go to the answer

Author Question: A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive ... (Read 22 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive bladder (OAB).
 
  The nurse teaches the patient what to do if side effects occur. Which statement by the patient indicates the need for further teaching?
  a. I can use sugar-free gum for dry mouth.
  b. I may need laxatives for constipation.
  c. I should keep the site covered to prevent other people from getting the medicine.
  d. I will take Benadryl for any itching caused by a local reaction to the patch.

Question 2

An older adult patient who lives alone and is somewhat forgetful has an overactive bladder and reports occasional constipation. Which treatment will the nurse anticipate for this patient?
 
  a. Behavioral therapy
  b. Oxybutynin (Ditropan XL) extended-release tablets
  c. Oxybutynin (Oxytrol) transdermal patch
  d. Percutaneous tibial nerve stimulation (PTNS)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

ANS: D
Benadryl is an antihistamine, and even though it is not classified as a muscarinic antagonist, it has anticholinergic effects. Giving it with a muscarinic antagonist greatly enhances these effects, so it should not be used. Muscarinic antagonists cause dry mouth, and patients should be taught to use sugar-free gum or candies to help with this. Muscarinic antagonists can cause constipation, and laxatives may be used. Medication applied topically can be transferred to others who come in contact with the skin, so the site should be covered.

Answer to Question 2

ANS: C
The transdermal patch is applied weekly and may be the best option for a patient who is more likely to forget to take a daily medication. The transdermal preparation has fewer side effects than the systemic dose so is less likely to increase this patient's constipation. Behavioral therapy should be tried first in patients who can participate. However, it is not the best option for a forgetful patient who lives alone, because it requires scheduled voiding and timing of fluid intake. The extended-release tablets must be given daily, and this patient may not remember to take them. PTNS is used after behavioral and drug therapies have failed.




james9437

  • Member
  • Posts: 568
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


nguyenhoanhat

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Gracias!

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

For a complete list of videos, visit our video library